207 results on '"Cristina Vilaplana"'
Search Results
102. Can systems immunology lead tuberculosis eradication?
- Author
-
Lilibeth Arias, Pere-Joan Cardona, Clara Prats, P. J. Cardona, Martí Català, Daniel López, Marta Arch, Sergio Alonso, Cristina Vilaplana, Universitat Politècnica de Catalunya. Departament de Física, and Universitat Politècnica de Catalunya. BIOCOM-SC - Grup de Biologia Computacional i Sistemes Complexos
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Agent-based model ,Tuberculosis ,Tuberculosi ,Systems biology ,Matemàtiques i estadística::Matemàtica aplicada a les ciències [Àrees temàtiques de la UPC] ,General Biochemistry, Genetics and Molecular Biology ,World health ,03 medical and health sciences ,Mathematical model ,Political science ,Active tb ,Drug Discovery ,medicine ,Intensive care medicine ,Systems immunology ,Mathematical models ,Granuloma ,Applied Mathematics ,Repertoire ,Models matemàtics ,medicine.disease ,Computer Science Applications ,Natural history ,030104 developmental biology ,Modeling and Simulation ,Identification (biology) - Abstract
25 years after the declaration of a Global Emergency by the World Health Organization, tuberculosis (TB) remains a major enemy to the humankind. During this period, much progress has been done to better understand its natural history, revealing its huge complexity, which highlighted the need for implementing systems immunology approaches. Recent advances focused in understanding the role of macrophage subtypes and dendritic cells role, the importance of cytokine balance, and the antigenic repertoire. Identification of early irruption of polymorphonuclear neutrophils and extracellular growth of the bacilli seem to be the most disruptive factors to understand the evolution towards active TB. Their inclusion in future models will provide new tools for the better understanding of the tuberculosis.
- Published
- 2018
- Full Text
- View/download PDF
103. A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis
- Author
-
Benoit Sansas, Cristina Vilaplana, Geneviève Inchauspé, Nathalie Silvestre, Aurélie Ray, Charles Antoine Coupet, Jean-Baptiste Marchand, Patricia Kleinpeter, H. Schultz, Chantal Hoffmann, Eric L. Nuermberger, Doris Schmitt, Khisimuzi Mdluli, Pere-Joan Cardona, Heena Soni, Sandeep Tyagi, Stéphane Leung-Theung-Long, Marie Gouanvic, Paul J. Converse, and Lilibeth Arias
- Subjects
0301 basic medicine ,Modified vaccinia Ankara ,Physiology ,medicine.medical_treatment ,Antibiotics ,Antitubercular Agents ,lcsh:Medicine ,Biochemistry ,Immune Physiology ,Tuberculosis, Multidrug-Resistant ,Vaccines, DNA ,Medicine and Health Sciences ,Public and Occupational Health ,Enzyme-Linked Immunoassays ,lcsh:Science ,Immune Response ,Vaccines ,Immune System Proteins ,Multidisciplinary ,biology ,Antimicrobials ,Drugs ,Combination chemotherapy ,Animal Models ,Vaccination and Immunization ,3. Good health ,Actinobacteria ,Vaccination ,Treatment Outcome ,Infectious Diseases ,Experimental Organism Systems ,Drug Therapy, Combination ,Research Article ,Infectious Disease Control ,medicine.drug_class ,Immunology ,030106 microbiology ,Enzyme-Linked Immunosorbent Assay ,Mouse Models ,Research and Analysis Methods ,Microbiology ,Antibodies ,Mycobacterium tuberculosis ,03 medical and health sciences ,Model Organisms ,Immune system ,Antigen ,Microbial Control ,medicine ,Humans ,Immunoassays ,Pharmacology ,Bacteria ,business.industry ,lcsh:R ,Organisms ,Biology and Life Sciences ,Proteins ,Viral Vaccines ,Immunotherapy ,biology.organism_classification ,030104 developmental biology ,Immunologic Techniques ,lcsh:Q ,Preventive Medicine ,business - Abstract
Despite the existence of the prophylactic Bacille Calmette-Guérin (BCG) vaccine, infection by Mycobacterium tuberculosis (Mtb) remains a major public health issue causing up to 1.8 million annual deaths worldwide. Increasing prevalence of Mtb strains resistant to antibiotics represents an urgent threat for global health that has prompted a search for alternative treatment regimens not subject to development of resistance. Immunotherapy constitutes a promising approach to improving current antibiotic treatments through engagement of the host’s immune system. We designed a multi-antigenic and multiphasic vaccine, based on the Modified Vaccinia Ankara (MVA) virus, denoted MVATG18598, which expresses ten antigens classically described as representative of each of different phases of Mtb infection. In vitro analysis coupled with multiple-passage evaluation demonstrated that this vaccine is genetically stable, i.e. fit for manufacturing. Using different mouse strains, we show that MVATG18598 vaccination results in both Th1-associated T-cell responses and cytolytic activity, targeting all 10 vaccine-expressed Mtb antigens. In chronic post-exposure mouse models, MVATG18598 vaccination in combination with an antibiotic regimen decreases the bacterial burden in the lungs of infected mice, compared with chemotherapy alone, and is associated with long-lasting antigen-specific Th1-type T cell and antibody responses. In one model, co-treatment with MVATG18598 prevented relapse of the disease after treatment completion, an important clinical goal. Overall, results demonstrate the capacity of the therapeutic MVATG18598 vaccine to improve efficacy of chemotherapy against TB. These data support further development of this novel immunotherapeutic in the treatment of Mtb infections.
- Published
- 2018
104. Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates: Table 1
- Author
-
Cristina Vilaplana, Niaina Rakotosamimanana, Klaus Reither, Mahdad Noursadeghi, Abraham Aseffa, Leopold Tientcheu Djomkam, Adrie JC Steyn, Eleni Aklillu, Giuseppe Ippolito, Paul Elkington, Matthew Bates, Sebastien Gagneux, James Baligeh Walter Russell, Nesri Padayatchi, Pere-Joan Cardona, Gavin Churchyard, Christian Wejse, Shreemanta K Parida, Timothy D McHugh, Clara Menéndez, Markus Maeurer, Vanya Gant, Robert S. Wallis, Dorothy Yeboah-Manu, Aziz Sheikh, Robert Wilkinson, Bassirou Diarra, and Professor Sir Alimuddin Zumla
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,biology ,business.industry ,Multi-drug-resistant tuberculosis ,Psychological intervention ,Drug resistance ,medicine.disease ,Precision medicine ,biology.organism_classification ,3. Good health ,Surgery ,Clinical trial ,Mycobacterium tuberculosis ,Infectious Diseases ,medicine ,Drug pipeline ,Intensive care medicine ,business - Abstract
Tuberculosis remains a global emergency causing an estimated 1.5 million deaths annually. For several decades the major focus of tuberculosis treatment has been on antibiotic development targeting Mycobacterium tuberculosis. The lengthy tuberculosis treatment duration and poor treatment outcomes associated with multi-drug resistant tuberculosis (MDR-TB) are of major concern. The sparse new tuberculosis drug pipeline and widespread emergence of MDR-TB signal an urgent need for more innovative interventions to improve treatment outcomes. Building on the historical Pasteur-Bechamp debates on the role of the "microbe" vs the "host internal milieu" in disease causation, we make the case for parallel investments into host-directed therapies (HDTs). A range of potential HDTs are now available which require evaluation in randomized controlled clinical trials as adjunct therapies for shortening the duration of tuberculosis therapy and improving treatment outcomes for drug-susceptible tuberculosis and MDR-TB. Funder initiatives that may enable further research into HDTs are described.
- Published
- 2015
- Full Text
- View/download PDF
105. Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction
- Author
-
J.D. Neuhaus, Petra Hillinger, Philip Haaf, M. Gabutti, Christian Mueller, M. Rubini Gimenez, Paola Ballarino, Cathrin Balmelli, Karin Wildi, Christa Zellweger, Stefan Osswald, A. Naduvilekoot, C. Jäger, Raphael Twerenbold, Berit Moehring, A. Al Afify, B. Darbouret, Sophie Druey, Stefan Ebmeyer, Cristina Vilaplana, and Tobias Reichlin
- Subjects
Male ,medicine.medical_specialty ,Internationality ,Myocardial Infarction ,Cohort Studies ,Copeptin ,Troponin T ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Humans ,In patient ,Prospective Studies ,Myocardial infarction ,Mortality ,Risk factor ,Survival rate ,Aged ,Aged, 80 and over ,biology ,business.industry ,Glycopeptides ,Middle Aged ,Prognosis ,medicine.disease ,Troponin ,Early Diagnosis ,Cohort ,biology.protein ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Follow-Up Studies - Abstract
Diabetes is a major risk factor for acute myocardial infarction (AMI). Assessment of diabetic patients is challenging due to an often atypical presentation of symptoms. We aimed to evaluate the two novel biomarkers copeptin and high-sensitive cardiac troponin (hs-TnT) for the improvement of early diagnosis and risk-stratification in patients with diabetes and suspected AMI.In this prospective international multicenter study we evaluated 379 patients with diabetes in a cohort of 1991 patients presenting with symptoms suggestive of AMI. The measurement of biomarkers was performed at presentation.Among the 379 diabetic patients, 32.7% had AMI, and in the 1621 patients without diabetes, 18.8% had AMI. The additional use of copeptin improved the diagnostic accuracy provided by conventional troponin alone (AUC 0.86 vs. 0.79, p=0.004). During a median follow-up of 814 days, 49 (13.1%) diabetic patients died. Cumulative 2-year survival rate for patients with copeptin levels below 9 pmol/l was 96.6% compared to 82.8% in patients above that level (p0.001). The same was observed for hs-TnT with a cutoff level of 14 ng/l (97.7% vs. 82.0%, p0.001) respective of cTnT with a cutoff level of 10 ng/l (93.5% vs. 75.6%, p0.001). In multivariate Cox analysis, copeptin, hs-TnT and cTnT were strong and independent predictors of 24-month-mortality. Using the dual marker strategy (copeptin and troponin) identified two groups of high-risk patients where 22.5% of the group with hs-cTnT and copeptin above the cutoff and 28.6% with cTnT and copeptin above the cutoff died.In diabetic patients, copeptin only slightly improves the early diagnosis of AMI provided by hs-cTnT. However, both markers (copeptin and troponin) predict long-term mortality accurately and independently of each other.
- Published
- 2015
- Full Text
- View/download PDF
106. An Estimation of the Value of Informal Care Provided to Dependent People in Spain
- Author
-
Luz María Peña-Longobardo, Cristina Vilaplana-Prieto, and Juan Oliva-Moreno
- Subjects
Adult ,Male ,Economics and Econometrics ,Economic growth ,medicine.medical_specialty ,Adolescent ,Social Values ,Home Nursing ,Social value orientations ,Health administration ,Disability Evaluation ,Surveys and Questionnaires ,medicine ,Humans ,Disabled Persons ,Child ,Aged ,Demography ,Estimation ,Contingent valuation ,Health economics ,business.industry ,Health Policy ,Public health ,General Medicine ,Middle Aged ,Caregivers ,Spain ,Value (economics) ,Workforce ,Female ,Demographic economics ,business - Abstract
The aim of this paper was to arrive at an approximation of the value of non-professional (informal) care provided to disabled people living within a household in Spain.We used the Survey on Disabilities, Autonomy and Dependency carried out in 2008 to obtain information about disabled individuals and their informal caregivers. We computed the total number of informal caregiving hours provided by main caregivers in Spain in 2008. The monetary value of informal care time was obtained using three different approaches: the proxy good method, the opportunity cost method and the contingent valuation method.Total hours of informal care provided in 2008 were estimated at 4193 million and the monetary value ranged from EUR23,064 to EUR50,158 million depending on the method used. The value of informal care was estimated at figures equivalent to 1.73-4.90 % of the gross domestic product for that year.Informal care represents a very high social cost regardless of the estimation method considered. A holistic approach to care of dependent people should take into account the role and needs of informal caregivers, promote their social recognition and lead to policies that enhance efficient use of formal and informal resources.
- Published
- 2015
- Full Text
- View/download PDF
107. Informal Care Motivations and Intergenerational Transfers in European Countries
- Author
-
Sergi Jimenez-Martin and Cristina Vilaplana Prieto
- Subjects
Long-term care ,Labour economics ,Work (electrical) ,Order (exchange) ,Health Policy ,media_common.quotation_subject ,Well-being ,Economics ,Total income ,Altruism ,Welfare ,Public care ,media_common - Abstract
This work sets out to analyze the motivations adult children may have to provide informal care, considering the monetary transfers they receive from their parents. Traditional motivations, such as altruism and exchange, are matched against more recent social bond theories. Our findings indicate that informal caregivers receive less frequent and less generous transfers than non-caregivers; that is, caregivers are more prone to suppress their self-interested motivations in order to prioritize the well being of another person. Additionally, long-term public care benefits increase both the probability of receiving a transfer and its amount, with this effect being more intense for both the poorest and richest households. Our findings suggest that if long-term care benefits are intended to increase the recipients' welfare and represent a higher fraction of total income for the poorest households, the effectiveness of these long-term care policies may be diluted.
- Published
- 2015
- Full Text
- View/download PDF
108. Unmet needs in formal care: kindling the spark for caregiving behavior
- Author
-
Cristina Vilaplana Prieto and Sergi Jimenez-Martin
- Subjects
Actuarial science ,Health economics ,Eurobarometer ,business.industry ,Health Policy ,media_common.quotation_subject ,Economics, Econometrics and Finance (miscellaneous) ,Payment ,Health administration ,Social security ,Simultaneous equations model ,Argument ,Medicine ,Demographic economics ,Endogeneity ,business ,media_common - Abstract
This paper studies if a situation of formal care unmet needs is a strong motivation for the onset of caregiving behavior, and if becoming caregiving is a compelling argument for leaving current job (in the presence/absence of formal care unmet needs). We use data from the Eurobarometer 67.3 for 18 European countries and estimate a three simultaneous equations model taking into account the potential endogeneity of labor participation and formal care unmet needs and assuming non-zero correlation among the error terms of the three equations. Results show that individuals who anticipate that becoming caregiver can suppose an obstacle for continuing working feel more refractory and are more prone to avoid caregiving responsibilities. Knowing someone with an unmet needs problem increases the probability of becoming caregiver by +19.23 pp (with a maximum of +39.39 pp for difficult access unmet needs) and raises the probability of leaving employment by 5.77 pp. Having to possibility of receiving economic benefits for caregivers encourage more labor market exit as compared to payment of social security contributions during care leaves.
- Published
- 2015
- Full Text
- View/download PDF
109. Effect of low-dose aspirin in a murine model of active tuberculosis
- Author
-
Jorge Díaz, Cristina Vilaplana, Vera Marie Kroesen, Gustavo Tapia, Pere-Joan Cardona, and Eric García
- Subjects
Murine model ,business.industry ,Medicine ,Pharmacology ,business ,Active tuberculosis ,Low dose aspirin - Published
- 2017
- Full Text
- View/download PDF
110. Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif
- Author
-
Jorge Carrillo, F.-Xabier Contreras, Eneritz Bilbao, Nuria Izquierdo-Useros, María Luisa Rodríguez de la Concepción, Bonaventura Clotet, Elisabet García, Luis M. Molinos-Albert, Silvia Marfil, Maier Lorizate, Julià Blanco, Pere J. Cardona, Jordi Villà-Freixa, Javier Martinez-Picado, Jon Ander Nieto-Garai, Luis Agulló, Cristina Vilaplana, Martin Floor, Universitat de Vic - Universitat Central de Catalunya. Departament de Biociències, and Universitat de Vic - Universitat Central de Catalunya. Càtedra de la Sida i Malalties Relacionades
- Subjects
0301 basic medicine ,Membrane lipids ,Monophosphoryl Lipid A ,Immunoglobulins ,Antígens ,Bioinformatics ,Epitope ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Epitopes ,Membrane Lipids ,Mice ,0302 clinical medicine ,Immunogenicity, Vaccine ,Antigen ,Tetanus Toxoid ,VIH (Virus) ,Animals ,Immunodeficiency ,Antigens ,POPC ,Inmunoglobulinas ,Immunodeficiència ,Inmunodeficiencia ,Liposome ,Multidisciplinary ,Immunogenicity ,Toxoid ,Antígenos ,Sida -- Tractament ,Molecular biology ,Lipids ,HIV Envelope Protein gp41 ,Infecciones por VIH ,Mice, Inbred C57BL ,030104 developmental biology ,chemistry ,Lípids ,Lípidos ,Female ,Infeccions per VIH ,lipids (amino acids, peptides, and proteins) ,Peptides ,Immunoglobulines ,030217 neurology & neurosurgery ,HIV infections - Abstract
Altres ajuts: Programa HIVACAT, programa CERCA (Generalitat de Catalunya), Red Temática Cooperativa de Investigación en SIDA (RD12/0017/0002)), Govern Basc (IT838-13), Spanish Supercomputing Network (grant numbers BCV-2015-2-0009 and BCV-2016-2-0005) The HIV-1 gp41 Membrane Proximal External Region (MPER) is recognized by broadly neutralizing antibodies and represents a promising vaccine target. However, MPER immunogenicity and antibody activity are influenced by membrane lipids. To evaluate lipid modulation of MPER immunogenicity, we generated a 1-Palmitoyl-2-oleoylphosphatidylcholine (POPC)-based proteoliposome collection containing combinations of phosphatidylserine (PS), GM3 ganglioside, holesterol (CHOL), sphingomyelin (SM) and the TLR4 agonist monophosphoryl lipid A (MPLA). A recombinant gp41-derived miniprotein (gp41-MinTT) exposing the MPER and a tetanus toxoid (TT) peptide that favors MHC-II presentation, was successfully incorporated into lipid mixtures (>85%). Immunization of mice with soluble gp41-MinTT exclusively induced responses against the TT peptide, while POPC proteoliposomes generated potent anti-gp41 IgG responses using lower protein doses. The combined addition of PS and GM3 or CHOL/SM to POPC liposomes greatly increased gp41 immunogenicity, which was further enhanced by the addition of MPLA. Responses generated by all proteoliposomes targeted the N-terminal moiety of MPER overlapping the 2F5 neutralizing epitope. Our data show that lipids impact both, the epitope targeted and the magnitude of the response to membrane-dependent antigens, helping to improve MPER-based lipid carriers. Moreover, the identification of immunodominant epitopes allows for the redesign of immunogens targeting MPER neutralizing determinants.
- Published
- 2017
111. Pilot, double-blind, randomized, placebocontrolled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity
- Author
-
Cristina Vilaplana, P. J. Cardona, Pere-Joan Cardona, Eva Montané, Núria Pérez-Álvarez, Yolanda Sanz, Ana Lucía Arellano, Ana María Barriocanal, and Angelica Valderrama
- Subjects
Bacterial Diseases ,Male ,0301 basic medicine ,Physiology ,lcsh:Medicine ,Pilot Projects ,Drug research and development ,Biochemistry ,law.invention ,Placebos ,Clinical trials ,Randomized controlled trial ,law ,Immune Physiology ,Cellular types ,Medicine and Health Sciences ,lcsh:Science ,education.field_of_study ,Immune System Proteins ,Multidisciplinary ,Latent tuberculosis ,Phase I clinical investigation ,Immune cells ,Regulatory T cells ,Actinobacteria ,Infectious Diseases ,Tolerability ,Research Design ,White blood cells ,Female ,Research Article ,Adult ,Cell biology ,Blood cells ,medicine.medical_specialty ,Randomization ,Clinical Research Design ,Immunology ,Population ,T cells ,Research and Analysis Methods ,Placebo ,Microbiology ,Mycobacterium ,Young Adult ,03 medical and health sciences ,Double-Blind Method ,Latent Tuberculosis ,Internal medicine ,medicine ,Tuberculosis ,Humans ,Antigens ,education ,Adverse effect ,Pharmacology ,Microbial Viability ,Bacteria ,business.industry ,Probiotics ,lcsh:R ,Organisms ,Biology and Life Sciences ,Proteins ,Tropical Diseases ,medicine.disease ,Clinical trial ,030104 developmental biology ,Animal cells ,Clinical medicine ,Dietary Supplements ,lcsh:Q ,Adverse Events ,business ,Mycobacterium Tuberculosis - Abstract
Background Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-like lesions. Methods Double-blind, randomized, placebo-controlled Clinical Trial (51 volunteers included). Two different doses of NR and a placebo were tested, the randomization was stratified by Latent Tuberculosis Infection (LTBI)-positive (n = 21) and LTBI-negative subjects (n = 30). Each subject received 14 drinkable daily doses for 2 weeks. Results All patients completed the study. The 46.3% of the overall reported adverse events (AE) were considered related to the investigational treatment. None of them were severe (94% were mild and 6% moderate). No statistical differences were found when comparing the median number of AE between the placebo group and both treatment groups. The most common AE reported were gastrointestinal events, most frequently mild abdominal pain and increase in stool frequency. Regarding the immunogenic response, both LTBI-negative and LTBI-positive volunteers treated with NR experienced a global increase on the Treg response, showed both in the population of CD25+CD39-, mainly effector Treg cells, or CD25+CD39+ memory PPD-specific Treg cells. Conclusion This clinical trial demonstrates an excellent tolerability profile of NR linked to a significant increase in the population of specific effector and memory Tregs in the groups treated with NR in both LTBI-positive and negative subjects. NR shows a promising profile to be used to reduce the risk of active TB.
- Published
- 2017
112. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
- Author
-
Santiago Uranga, Vicente Ausina, Conchita Fernandez, Juan Ignacio Aguilo, Wladimir Malaga, Cristina Vilaplana, Brigitte Gicquel, Simon Clark, Pere-Joan Cardona, Ainhoa Arbues, Alberto Parra, Ann Williams, Eugenia Puentes, Carlos Martin, Dessislava Marinova, Christophe Guilhot, and Jesús Gonzalo-Asensio
- Subjects
Male ,Tuberculosis ,Virulence Factors ,Guinea Pigs ,Virulence ,Disease ,Vaccines, Attenuated ,Mycobacterium tuberculosis ,Mice ,03 medical and health sciences ,Bacterial Proteins ,medicine ,Animals ,Tuberculosis Vaccines ,Gene ,030304 developmental biology ,0303 health sciences ,General Veterinary ,General Immunology and Microbiology ,biology ,030306 microbiology ,Genetically engineered ,business.industry ,Public Health, Environmental and Occupational Health ,biology.organism_classification ,medicine.disease ,Virology ,3. Good health ,Clinical trial ,Disease Models, Animal ,Infectious Diseases ,Immunology ,Molecular Medicine ,Female ,Tuberculosis vaccines ,business ,Gene Deletion - Abstract
The development of a new tuberculosis vaccine is an urgent need due to the failure of the current vaccine, BCG, to protect against the respiratory form of the disease. MTBVAC is an attenuated Mycobacterium tuberculosis vaccine candidate genetically engineered to fulfil the Geneva consensus requirements to enter human clinical trials. We selected a M. tuberculosis clinical isolate to generate two independent deletions without antibiotic-resistance markers in the genes phoP, coding for a transcription factor key for the regulation of M. tuberculosis virulence, and fadD26, essential for the synthesis of the complex lipids phthiocerol dimycocerosates (DIM), one of the major mycobacterial virulence factors. The resultant strain MTBVAC exhibits safety and biodistribution profiles similar to BCG and confers superior protection in preclinical studies. These features have enabled MTBVAC to be the first live attenuated M. tuberculosis vaccine to enter clinical evaluation.
- Published
- 2013
- Full Text
- View/download PDF
113. Impacto sobre las cotizaciones sociales de la integracióndel Sistema Especial de Empleados del Hogar en el RégimenGeneral: aplicación a los empleados que atienden a personas en situación de dependencia
- Author
-
Cristina Vilaplana Prieto
- Subjects
Economics and Econometrics ,Finance - Abstract
Este trabajo aborda la integracion del sistema Especial de Empleados del Hogar en el regimen Ge-neral de la seguridad social utilizando informacion sobre empleados del hogar que atienden a per-sonas dependientes. se han comparado los efectos del real Decreto 1620/2011 y real Decreto-ley29/2012. Esta segunda reforma supone una reduccion del ahorro en las cuotas por contingencias co-munes y profesionales de las que se beneficiaban empleados y empleadores con la primera reforma.las simulaciones de ingresos de la Tesoreria de la seguridad social durante 2013-2019, en los dife-rentes escenarios, muestran un incremento de los ingresos con el segundo texto legislativo.
- Published
- 2013
- Full Text
- View/download PDF
114. Impacto sobre las cotizaciones sociales de la integración del Sistema Especial de Empleados del Hogar en el Régimen General: aplicación a los empleados que atienden a personas en situación de dependencia
- Author
-
Cristina Vilaplana Prieto
- Subjects
Empleador, empleado del hogar, cotizaciones sociales, Seguridad Social ,jel:J38 ,jel:H55 - Abstract
Este trabajo aborda la integración del sistema Especial de Empleados del Hogar en el Régimen General de la Seguridad Social utilizando información sobre empleados del hogar que atienden a personas dependientes. Se han comparado los efectos del Real Decreto 1620/2011 y Real Decreto-Ley 29/2012. Esta segunda reforma supone una reducción del ahorro en las cuotas por contingencias comunes y profesionales de las que se beneficiaban empleados y empleadores con la primera reforma. Las simulaciones de ingresos de la Tesorería de la Seguridad Social durante 2013-2019, en los diferentes escenarios, muestran un incremento de los ingresos con el segundo texto legislativo.
- Published
- 2013
115. Evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures
- Author
-
Joaquim Valls, Daniel López, Neus Cáceres, Elena Marzo, Clara Prats, Isaac Llopis, Pere-Joan Cardona, and Cristina Vilaplana
- Subjects
Microbiology (medical) ,Bacilli ,Immunology ,Colony Count, Microbial ,Polysorbates ,Optical density ,Microbiology ,Mycobacterium tuberculosis ,03 medical and health sciences ,Stress, Physiological ,Freezing ,Image Processing, Computer-Assisted ,Extracellular ,Cell Aggregations ,Cell Aggregation ,030304 developmental biology ,0303 health sciences ,biology ,030306 microbiology ,Biofilm ,biology.organism_classification ,Cell aggregation ,3. Good health ,Infectious Diseases ,Stationary phase ,Biofilms ,Microscopy, Electron, Scanning ,Cord Factors - Abstract
The aim of this study was to evaluate the evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures according to growth time and conditions. Thus, in standard culture using aerated 7H9 Middlebrook broth supplemented with 0.05% Tween 80, a dramatic CFU decrease was observed at the end of the exponential phase. This phase was followed by a stable stationary phase that led to dissociation between the optical density (O.D.) and CFU values, together with the formation of opaque colonies in solid culture. Further analysis revealed that this was due to cording. Scanning electron microscopy showed that cording led to the formation of very stable coiled structures and corded cell aggregations which proved impossible to disrupt by any of the physical means tested. Modulation of cording with a high but non-toxic concentration of Tween 80 led to a slower growth rate, avoidance of a sudden drop-off to the stationary phase, the formation of weaker cording structures and the absence of opaque colonies, together with a lower survival at later time-points. An innovative automated image analysis technique has been devised to characterize the cording process. This analysis has led to important practical consequences for the elaboration of M. tuberculosis inocula and suggests the importance of biofilm formation in survival of the bacilli in the extracellular milieu.
- Published
- 2013
- Full Text
- View/download PDF
116. A literary approach to tuberculosis: lessons learned from Anton Chekhov, Franz Kafka, and Katherine Mansfield
- Author
-
Cristina Vilaplana
- Subjects
Microbiology (medical) ,Literature, Modern ,Tuberculosis ,Famous Persons ,MEDLINE ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Chekhov ,Humans ,Medicine ,lcsh:RC109-216 ,030212 general & internal medicine ,Tuberculosis, Pulmonary ,Kafka ,business.industry ,030503 health policy & services ,History, 19th Century ,General Medicine ,History, 20th Century ,Mansfield ,medicine.disease ,Mental health ,Infectious Diseases ,Literature ,Famous persons ,0305 other medical science ,business ,Classics - Abstract
Letters by notable writers from the past century can provide valuable information on the times in which they lived. In this article, attention is drawn to the lessons learned from three famous writers who died of tuberculosis: Anton Chekhov, Franz Kafka, and Katherine Mansfield. The characteristics of the course of the disease in the pre-antibiotic era and the importance of addressing mental health in the management of tuberculosis are discussed.
- Published
- 2016
- Full Text
- View/download PDF
117. Evaluation of reading achievement of the program school 2.0 in Spain using PISA 2012
- Author
-
Cristina Vilaplana Prieto
- Published
- 2016
- Full Text
- View/download PDF
118. ENHANCING SUPPORTING BEHAVIOUR THROUGH ICT: EVIDENCE FOR SPAIN
- Author
-
Cristina Vilaplana-Prieto
- Subjects
Knowledge management ,Information and Communications Technology ,business.industry ,Business - Published
- 2016
- Full Text
- View/download PDF
119. Influencia de los programas universitarios para mayores sobre la mejora del rendimiento cognitivo
- Author
-
Cristina Vilaplana Prieto
- Subjects
programas universitarios para mayores ,beneficios ,cognitive achievement ,satisfaction ,satisfacción ,General Medicine ,benefits ,Third Age University Programs ,rendimiento cognitivo - Abstract
The aim of this paper is to apply a rigorous econometric approach to analyze the benefits derived from participation in Third Age University Programs (3AUP). Two waves from the SHARE (Survey of Health, Ageing and Retirement in Europe) corresponding to 2007 and 2011 are used. This survey contains information concerning the degree of satisfaction with life and allows to define indicators for cognitive achievement in memory, vocabulary and fluency. A sample of individuals aged between 50 and 85 years old is selected. The percentage of participants in 3AUP has increased from 3.25 % to 5.47 %, which represents an average growth rate of 13.90 %. For the sample of all respondents we appreciate that: (i) the probability of retaining 10-14 words in the memory test increases by 0.34 points for participants in 3AUP, (ii) the probability of developing a list with at least twenty words increases by 0.45 points for participants in 3AUP, and it attains a maximum of 0.88 point for participants with high school education. El objetivo de este trabajo es aplicar un enfoque econométrico riguroso para analizar los beneficios derivados de la participación en programas universitarios para mayores (PUM) en España. Se utilizan dos olas de la encuesta SHARE (Survey of Health, Ageing and Retirement in Europe) para 2007 y 2011. Esta encuesta contiene información sobre el nivel de satisfacción general y permite construir indicadores para pruebas cognitivas de memoria. Se selecciona una muestra de personas de entre 50 y 85 años. El porcentaje de participantes ha aumentado del 3,25 % al 5,47 %. Por tanto, en el intervalo de cuatro años la tasa de participación ha crecido a una tasa media anual acumulada del 13,90 %. Para el conjunto de todos los individuos se constata que: i) la probabilidad de recordar entre 10 y 14 palabras en la prueba de memoria aumenta en 0,34 puntos si participa en PUM, y ii) la probabilidad de que la lista confeccionada en la prueba de fluidez contenga 20 o más nombres aumenta en 0,45 puntos, si participa en un PUM, con un máximo de 0,88 puntos de diferencia si tiene estudios secundarios.
- Published
- 2016
120. Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model
- Author
-
Pere-Joan Cardona, Joaquim Valls, Daniel López, Cristina Vilaplana, Clara Prats, Elena Marzo, Universitat Politècnica de Catalunya. Departament de Física, and Universitat Politècnica de Catalunya. BIOCOM-SC - Grup de Biologia Computacional i Sistemes Complexos
- Subjects
0301 basic medicine ,Microbiology (medical) ,Pathology ,medicine.medical_specialty ,Tuberculosis ,Ciències de la salut::Medicina [Àrees temàtiques de la UPC] ,Tuberculosi ,Inflammatory response ,030106 microbiology ,lcsh:QR1-502 ,Inflammation ,Disease ,Biology ,Tuberculosis lesions in lungs ,Microbiology ,lcsh:Microbiology ,dynamic hypothesis ,Mycobacterium tuberculosis ,03 medical and health sciences ,Animal model ,Active disease ,medicine ,lesions coalescence ,Tuberculosis-Research ,Original Research ,active tuberculosis ,Computational model ,dynamic hypothes ,Dynamic hypothesis ,medicine.disease ,biology.organism_classification ,Active tuberculosis ,tuberculosis lesions in lungs ,computational model ,030104 developmental biology ,Public Health ,medicine.symptom - Abstract
Altres ajuts: Miguel Servet CP13/00174 The evolution of a tuberculosis (TB) infection toward active disease is driven by a combination of factors mostly related to the host response. The equilibrium between control of the bacillary load and the pathology generated is crucial as regards preventing the growth and proliferation of TB lesions. In addition, some experimental evidence suggests an important role of both local endogenous reinfection and the coalescence of neighboring lesions. Herein we propose a mathematical model that captures the essence of these factors by defining three hypotheses: (i) lesions grow logistically due to the inflammatory reaction; (ii) new lesions can appear as a result of extracellular bacilli or infected macrophages that escape from older lesions; and (iii) lesions can merge when they are close enough. This model was implemented in Matlab to simulate the dynamics of several lesions in a 3D space. It was also fitted to available microscopy data from infected C3HeB/FeJ mice, an animal model of active TB that reacts against Mycobacterium tuberculosis with an exaggerated inflammatory response. The results of the simulations show the dynamics observed experimentally, namely an initial increase in the number of lesions followed by fluctuations, and an exponential increase in the mean area of the lesions. In addition, further analysis of experimental and simulation results show a strong coincidence of the area distributions of lesions at day 21, thereby highlighting the consistency of the model. Three simulation series removing each one of the hypothesis corroborate their essential role in the dynamics observed. These results demonstrate that three local factors, namely an exaggerated inflammatory response, an endogenous reinfection, and a coalescence of lesions, are needed in order to progress toward active TB. The failure of one of these factors stops induction of the disease. This mathematical model may be used as a basis for developing strategies to stop the progression of infection toward disease in human lungs
- Published
- 2016
121. 11 Murine model to predict viral rebound in HIV+ allotransplanted subjects
- Author
-
Manuel Jurado, Jose Luis Dı́ez, Monique Nijhuis, Alessandra Bandera, Maria Cristina O. Salgado, Cristina Gálvez, Cristina Vilaplana, Mi Kwon, Annemarie M. J. Wensing, Jon Badiola, and Javier Martinez-Picado
- Subjects
0301 basic medicine ,Viral rebound ,Epidemiology ,business.industry ,Immunology ,Public Health, Environmental and Occupational Health ,Human immunodeficiency virus (HIV) ,medicine.disease_cause ,Virology ,Microbiology ,QR1-502 ,03 medical and health sciences ,030104 developmental biology ,Infectious Diseases ,Murine model ,Medicine ,Public aspects of medicine ,RA1-1270 ,business - Published
- 2017
122. El valor social de los cuidados informales provistos a personas mayores en situación de dependencia en España
- Author
-
Juan Oliva, Rubén Osuna, and Cristina Vilaplana
- Subjects
Gerontology ,education.field_of_study ,biology ,Shadow price ,Costes no sanitarios ,Population ,Public Health, Environmental and Occupational Health ,MEDLINE ,Cuidados informales ,Euros ,Nonmedical costs ,Valor económico ,Personal autonomy ,Social value orientations ,biology.organism_classification ,Informal care ,Proxy (climate) ,Workforce ,Economic value ,Demographic economics ,Business ,education - Abstract
ResumenObjetivoEl objetivo de este trabajo es analizar una parte del beneficio social que proporcionan los cuidados no profesionales (informales), planteando el escenario hipotético de los recursos que habría que movilizar si hubiera que sustituir su labor.Métodos y datosEmpleando información de la Encuesta sobre Discapacidades, Autonomía personal y situaciones de Dependencia 2008 (EDAD-08) se ha realizado un ejercicio de simulación sobre el coste que tendría que asumir la sociedad si reemplazara los cuidados informales a personas de 65 y más años de edad por servicios sociales profesionales. Para tal fin se estiman las horas de cuidados informales prestadas en España durante el año 2008 y se valoran monetariamente mediante el método de coste de sustitución.ResultadosLa traducción monetaria de las horas de cuidados informales prestados durante el año 2008 nos lleva a cifras que oscilan entre los 25.000 y los 40.000 millones de euros, dependiendo del precio sombra asignado a la hora de cuidado. Estas cifran serían equivalentes a entre un 2,3% y un 3,8% del producto interior bruto (PIB) del mismo año. Cuando nos trasladamos al ámbito regional, la valoración oscila de manera muy importante entre comunidades autónomas, llegando alguna a alcanzar cifras que equivalen a cerca de un 6% de su PIB.ConclusionesEl abordaje integral de los cuidados de las personas dependientes exige incluir el papel y la atención a las necesidades de las personas cuidadoras y avanzar en su reconocimiento social.AbstractObjectiveTo analyze one part of the social benefit derived from non-professional (informal) caregivers by analyzing the hypothetical amount of resources that would need to be invested if informal care were substituted by formal care.Methods and dataUsing data from the Survey of Disabilities, Personal Autonomy and Situations of Dependency (EDAD-2008), we estimated the cost to society if informal care were substituted by formal care of the population aged 65 years and older. For this purpose, first we computed the total amount of informal caregiving hours provided in Spain in 2008, and then we obtained its monetary worth by using the proxy good method.ResultsThe monetary worth of informal care provided in 2008 ranged from 25,000 and 40,000 million euros, depending on the shadow price used to value one hour of care. These figures represented between 2.3% and 3.8% of the GDP for the same year. In regional terms, the valuation of informal care across Spain's autonomous regions showed a significant degree of dispersion, and in some regions, amounted to 6% of their GDP.ConclusionsThe comprehensive approach to the care of the elderly should take the role and needs of informal caregivers into consideration. Caregivers should be given greater social recognition.
- Published
- 2011
- Full Text
- View/download PDF
123. Inmunodiagnóstico y biomarcadores en tuberculosis
- Author
-
Cristina Vilaplana, Pere-Joan Cardona, and Heinner Guio
- Subjects
education.field_of_study ,Tuberculosis ,Latent tuberculosis ,business.industry ,Population ,Tuberculin ,General Medicine ,medicine.disease ,Tuberculosis diagnosis ,Immunology ,Global health ,False positive paradox ,Medicine ,business ,education ,BCG vaccine - Abstract
Based on the tuberculin skin test it is estimated that latent tuberculosis infection is present in one-third of the world's population. The new strategies in public health and research are aimed to reduce and eradicate this enormous reservoir. However, the absence of effective biomarkers for diagnosis and treatment of latent tuberculosis limits the development of new drugs and vaccines. Some components are present in both, the PPD (used in the tuberculin skin test) and the BCG vaccine. This increases the number of false positives in vaccinated individuals. Nowadays, there is not an immune diagnostic method that can differentiate latent tuberculosis and tuberculosis disease. New studies have addressed some strategies including specific antibodies, new cytokines and / or antigens as candidates for biomarkers. However, the high costs of these studies, the low number of participants and their different methodology make difficult a future meta-analysis and more conclusive results.
- Published
- 2011
- Full Text
- View/download PDF
124. The trade-off between formal and informal care in Spain
- Author
-
Sergi Jimenez-Martin and Cristina Vilaplana Prieto
- Subjects
Adult ,Male ,Economic growth ,medicine.medical_specialty ,Time Factors ,Economics, Econometrics and Finance (miscellaneous) ,Context (language use) ,Sex Factors ,Economics ,medicine ,Humans ,Disabled Persons ,Family ,Aged ,Quality of Health Care ,Social policy ,Multinomial logistic regression ,Aged, 80 and over ,Geriatrics ,Health economics ,Marital Status ,Health Policy ,Public health ,Age Factors ,Health Services ,Middle Aged ,Mental illness ,medicine.disease ,Home Care Services ,Long-term care ,Models, Economic ,Caregivers ,Socioeconomic Factors ,Spain ,Income ,Female ,Demographic economics - Abstract
The remarkable growth of older population has moved long term care to the front ranks of the social policy agenda. Understanding the factors that determine the type and amount of formal care is important for predicting use in the future and developing long-term policy. In this context we jointly analyze the choice of care (formal, informal, both together or none) as well as the number of hours of care received. Given that the number of hours of care is not independent of the type of care received, we estimate, for the first time in this area of research, a sample selection model with the particularity that the first step is a multinomial logit model. With regard to the debate about complementarity or substitutability between formal and informal care, our results indicate that formal care acts as a reinforcement of the family care in certain cases: for very old care receivers, in those cases in which the individual has multiple disabilities, when many care hours are provided, and in case of mental illness and/or dementia. There exist substantial differences in long term care addressed to younger and older dependent people and dependent women are in risk of becoming more vulnerable to the shortage of informal caregivers in the future. Finally, we have documented that there are great disparities in the availability of public social care across regions.
- Published
- 2011
- Full Text
- View/download PDF
125. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant
- Author
-
Maria, Salgado, Mi, Kwon, Cristina, Gálvez, Jon, Badiola, Monique, Nijhuis, Alessandra, Bandera, Pascual, Balsalobre, Pilar, Miralles, Ismael, Buño, Carolina, Martinez-Laperche, Cristina, Vilaplana, Manuel, Jurado, Bonaventura, Clotet, Annemarie, Wensing, Javier, Martinez-Picado, Jose Luis, Diez-Martin, and Susanne, Loth
- Subjects
Adult ,Male ,0301 basic medicine ,Adoptive cell transfer ,Anti-HIV Agents ,medicine.medical_treatment ,Human immunodeficiency virus (HIV) ,HIV Infections ,Transplantation Chimera ,Hematopoietic stem cell transplantation ,HIV Antibodies ,medicine.disease_cause ,Mice ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Immunity ,Internal Medicine ,medicine ,Animals ,Humans ,Transplantation, Homologous ,030212 general & internal medicine ,business.industry ,Hematopoietic Stem Cell Transplantation ,General Medicine ,Viral Load ,Adoptive Transfer ,Hematologic Diseases ,Immunity, Humoral ,Transplantation ,surgical procedures, operative ,030104 developmental biology ,Case-Control Studies ,CD4 Antigens ,DNA, Viral ,Models, Animal ,Immunology ,HIV-1 ,RNA, Viral ,Stem cell ,business ,Viral load ,Follow-Up Studies - Abstract
Background: The multifactorial mechanisms associated with radical reductions in HIV-1 reservoirs after allogeneic hematopoietic stem cell transplant (allo-HSCT), including a case of HIV cure, are not fully understood. Objective: To investigate the mechanism of HIV-1 eradication associated with allo-HSCT. Design: Nested case series within the IciStem observational cohort. Setting: Multicenter European study. Participants: 6 HIV-infected, antiretroviral-treated participants who survived more than 2 years after allo-HSCT with CCR5 wildtype donor cells. Measurements: HIV DNA analysis, HIV RNA analysis, and quantitative viral outgrowth assay were performed in blood, and HIV DNA was also measured in lymph nodes, ilea, bone marrow, and cerebrospinal fluid. A humanized mouse model was used for in vivo detection of the replication-competent blood cell reservoir. HIV-specific antibodies were measured in plasma. Results: Analysis of the viral reservoir showed that 5 of 6 participants had full donor chimera in T cells within the first year after transplant, undetectable proviral HIV DNA in blood and tissue, and undetectable replication-competent virus (
- Published
- 2018
- Full Text
- View/download PDF
126. Abstract 3596: Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX)
- Author
-
Maria Teresa Herrera-Abreu, José Baselga, Carlos Caldas, Judit Grueso, Rodrigo Dienstmann, Violeta Serra, Javier Cortes, Marta Guzman, Faye Su, Maurizio Scaltriti, Meritxell Bellet, Joaquín Arribas, Cristina Saura, Mafalda Oliveira, Marta Palafox, Nicholas C. Turner, Alejandra Bruna, Cristina Vilaplana, Emmanuelle di Tomaso, and Olga Rodriguez
- Subjects
Cancer Research ,Fulvestrant ,business.industry ,Cancer ,Cell cycle ,Palbociclib ,medicine.disease ,Cyclin D1 ,Oncology ,In vivo ,CDKN2A ,Cancer research ,Medicine ,business ,Ex vivo ,medicine.drug - Abstract
The cell cycle G1-restriction point is frequently deregulated in HR+ BC by alterations of cyclin D1 (CCND1), p16 (CDKN2A) or pRb (RB1). CDK4/6i (ribociclib, abemaciclib and palbociclib) have shown clinical activity in metastatic HR+ BC, both as single agents and in combination with endocrine therapy. Currently, no biomarkers of response to CDK4/6i have been identified beyond HR expression and little is known about mechanisms of acquired resistance. Twenty-one PDXs were established from HR+, HER2+ or HR+/HER2+ BC patient biopsies and their response to ribociclib was evaluated in vivo and ex vivo in matrigel cultures. Acquired-resistance was generated in vivo by isolating tumors that escaped therapy overtime. In order to identify response biomarkers, genetic and proteomic analysis of PDXs were performed and correlated with ribociclib antitumor activity. Candidates were validated in a cohort of 8 tumor samples from patients treated with abemaciclib monotherapy and in vitro. Combination with the PI3K-alpha inhibitor (PI3Ki) BYL719 was explored in vivo. In vivo, ribociclib exhibited antitumor activity in five out of 21 PDXs (24%), two of which acquired resistance after continuous dosage (75mg/kg, 6IW). Ex vivo matrigel cultures recapitulated the in vivo response with 75% sensitivity and 92% specificity (p=0.01), providing a novel approach for high throughput screening. Baseline levels of ER, PR and Ki67 protein or PIK3CA/ESR1 mutations did not discriminate between ribociclib-resistant/sensitive PDXs, whereas CCND1/D2-amplification/overexpression were only found in ribociclib-resistant models. Importantly, sensitive PDXs exhibited significant Ki67 reduction upon ribociclib treatment, higher baseline pRb- and lower p16-staining compared to ribociclib-resistant PDXs (p=0.004, 0.02 and 0.03, respectively). Three out of 8 acquired-resistant tumors (37.5%) exhibited pRb loss. In vitro, RB1 knockdown and cyclin D1/D2-overexpression resulted in higher BrdU incorporation and higher IC50 than control cells upon ribociclib treatment. p16 expression was significantly lower in samples of patients exhibiting clinical benefit with abemaciclib monotherapy (p=0.04). Remarkably, combination of ribociclib with a PI3Ki resulted in appreciable antitumor activity in 18 out of 20 PDXs (90%), including two models resistant to fulvestrant given in combination with ribociclib. In conclusion, HR+, HER2+ and HR+/HER2+ BC PDXs expressing both high Rb- and low p16-protein levels are sensitive to CDK4/6i whereas deregulation of the G1-restriction point due to low pRb or high cyclin D1/D2 protein levels is associated with resistance to ribociclib monotherapy. Addition of a PI3Ki markedly improves the antitumor response of ribociclib in most of PDXs, suggesting that the PI3K pathway may play a pivotal role in limiting the efficacy of CDK4/6 inhibition. Citation Format: Marta Palafox, María Teresa Herrera-Abreu, Meritxell Bellet, Mafalda Oliveira, Alejandra Bruna, Olga Rodriguez, Marta Guzmán, Judit Grueso, Cristina Vilaplana, Joaquín Arribas, Emmanuelle di Tomaso, Faye Su, Carlos Caldas, Nicholas C. Turner, Rodrigo Dienstmann, José Baselga, Maurizio Scaltriti, Javier Cortés, Cristina Saura, Violeta Serra. Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 3596.
- Published
- 2018
- Full Text
- View/download PDF
127. Tuberculin immunotherapy: its history and lessons to be learned
- Author
-
Cristina Vilaplana and Pere-Joan Cardona
- Subjects
medicine.medical_specialty ,Tuberculosis ,business.industry ,Laboratory monitoring ,Immunology ,Tuberculin ,Historical Article ,History, 19th Century ,Mycobacterium chelonae ,History, 20th Century ,medicine.disease ,Microbiology ,Surgery ,Infectious Diseases ,medicine ,Humans ,Tuberculosis control ,Tuberculosis Vaccines ,Intensive care medicine ,business - Abstract
The use of tuberculin for the therapy of tuberculosis was attempted more than 100 years ago and abandoned because of its adverse reactions. In this historical review we point out that some of the intensive efforts to avoid the reactions were based on the best scientific rationale available at that time. Balancing the dosage and intervals of tuberculin delivery with clinical and laboratory monitoring of patients achieved a limited success, with implications, toward current research in the field. The role of economical and social aspects at that time is also a lesson to be learned toward current approaches to tuberculosis control.
- Published
- 2010
- Full Text
- View/download PDF
128. Conciliación entre vida laboral y cuidados informales a personas mayores dependientes en España
- Author
-
Cristina Vilaplana
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2010
- Full Text
- View/download PDF
129. Estimación de la dependencia en España a partir de la EDAD 2008
- Author
-
Cristina Vilaplana Prieto
- Subjects
jel:J14 ,jel:J11 ,dependency, disability, demographic forecasts ,jel:I10 - Abstract
The evolution of dependency in Spain will have a significant effect over long-term care demand. With the purpose of getting knowledge of the dimension of the dependent population, we apply the EDAD2008. Next, using the Short Term Demographic Projections drew up by INE, we develop different scenarios of dependency projections. We ascertain a growth of the institutionalization rate, a reduction of moderate dependency and an increase of high dependency, as well, as an acute process of dependency feminisation for the cohort older than 75 years. On the other hand, dependency projections point in favour of the morbidity compression model and exhibit a lesser dependency growth in comparison with previous estimations.
- Published
- 2010
130. Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
- Author
-
Sergio Pinto, Joan Costa, E. Montané, Ferran Torres, A.M. Barriocanal, Gema Domenech, Cristina Vilaplana, and P. J. Cardona
- Subjects
Adult ,Male ,medicine.medical_specialty ,Tuberculosis ,Adolescent ,Drug-Related Side Effects and Adverse Reactions ,Injections, Subcutaneous ,T-Lymphocytes ,Phases of clinical research ,Placebo ,law.invention ,Placebos ,Young Adult ,Double-Blind Method ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Tuberculosis Vaccines ,General Veterinary ,General Immunology and Microbiology ,Latent tuberculosis ,business.industry ,Public Health, Environmental and Occupational Health ,medicine.disease ,Healthy Volunteers ,Vaccination ,Clinical trial ,Blood ,Infectious Diseases ,Immunology ,Molecular Medicine ,Immunotherapy ,Tuberculosis vaccines ,business - Abstract
A Phase I interventional Clinical Trial was performed with a potential tuberculosis vaccine, based on detoxified cellular fragments of M. tuberculosis, named RUTI. The objective was to evaluate the safety profile and T-cell immune responses over a 6-month period following subcutaneous inoculation. The double-blind, randomized and placebo-controlled trial was conducted in healthy volunteers, all recruited at one site. RUTI, at each of the four tested doses, starting from 5microg and going up to 200microg, and placebo were inoculated to groups of 4 and 2 volunteers respectively, consecutively. RUTI appeared to be well tolerated as judged by local and systemic clinical evaluation, though vaccine dose dependent local adverse reactions were recorded. T-cell responses of blood lymphocytes to PPD and a number of antigen subunits were elevated, when compared with controls subjects. These results support the feasibility of future evaluation, to be targeted at subjects with latent tuberculosis infection (LTBI).
- Published
- 2010
- Full Text
- View/download PDF
131. Effectiveness and Safety of a Treatment Regimen Based on Isoniazid Plus Vaccination withMycobacterium tuberculosiscells’ Fragments: Field-Study with NaturallyMycobacterium caprae-Infected Goats
- Author
-
Emmanuel Serrano, Mariano Domingo, Miquel Nofrarías, Evelyn Guirado, Cristina Vilaplana, Olga Gil, B. Pérez, Neus Cáceres, P. J. Cardona, and M. Grassa
- Subjects
Tuberculosis ,medicine.medical_treatment ,Immunology ,Antitubercular Agents ,Mycobacterium ,Mycobacterium tuberculosis ,Interferon-gamma ,Isoniazid ,medicine ,Animals ,Tuberculosis Vaccines ,Adverse effect ,Antigens, Bacterial ,Chemotherapy ,biology ,Latent tuberculosis ,business.industry ,Goats ,General Medicine ,bacterial infections and mycoses ,Mycobacterium caprae ,biology.organism_classification ,medicine.disease ,Vaccination ,Female ,business ,medicine.drug - Abstract
The identification of a herd of goats with tuberculosis let us test a new treatment regimen against latent tuberculosis infection (LTBI). Using large animal experimental models allows a better approach to understanding human tuberculosis according to immunopathological parameters. Based on an initial study showing a correlation between the ESAT-6-specific interferon (IFN)-gamma secretion and the severity of pulmonary lesions, this parameter was used in combination with an X-ray examination to screen the animals to be included in the efficacy and safety studies. All the animals proved to be infected with Mycobacterium caprae. The efficacy study was run in animals distributed in three experimental groups according to treatment: untreated (CT), treated with isoniazid (INH), and treated with INH + RUTI (a vaccine based on M. tuberculosis cell fragments) inoculated twice. RUTI temporarily increased the IFN-gamma production after stimulating the peripheral blood with ESAT-6, purified protein derivative and RUTI in vitro. The INH chemotherapy reduced both pulmonary and extra pulmonary affectation, but not disease in pulmonary lymph nodes. The addition of RUTI may have decreased extrapulmonary disease further but had no benefit to lung or lung lymph-nodes itself. Safety studies showed that inoculation of RUTI caused a temporary increase of rectal temperature (1-2 degrees C) and local swelling, both adverse effects being well tolerated. Neither systemic toxicity nor mortality was induced by the vaccination. The control of goats' infection by the therapeutic regimen consisting in INH chemotherapy + RUTI as well as its safety, represented a further step towards testing its effects in human LTBI in a future.
- Published
- 2009
- Full Text
- View/download PDF
132. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models
- Author
-
Olga Gil, Gustavo Tapia, Sergio Pinto, Pere-Joan Cardona, Cristina Vilaplana, Neus Cáceres, Frédéric Altare, and Isabel Ojanguren
- Subjects
Microbiology (medical) ,Tuberculosis ,Guinea Pigs ,Immunology ,Biology ,Microbiology ,Mycobacterium tuberculosis ,Mice ,Necrosis ,Phagosomes ,Macrophages, Alveolar ,medicine ,Animals ,Electronic microscopy ,Pulmonary pathology ,Lung ,Tuberculosis, Pulmonary ,Granuloma ,medicine.disease ,biology.organism_classification ,Experimental tuberculosis ,Mice, Inbred C57BL ,Disease Models, Animal ,Microscopy, Electron ,Cholesterol ,Infectious Diseases ,Mice, Inbred DBA ,Chronic Disease ,Disease Progression ,Female ,Intracellular ,Foamy macrophages ,Foam Cells - Abstract
The chronic phase of Mycobacterium tuberculosis infection in mouse experimental models is characterized by the accumulation of foamy macrophages (FM)--which shape the outer ring of the granuloma - in the alveolar spaces, as detected in paraffin-embedded tissues stained with hematoxylin-eosin. In this study, the use of semi- and ultra-thin sections offers more detailed information about the origin of FM both in mouse and guinea-pig experimental models. Lipid bodies (LB) are present in macrophages from the beginning of infection and accumulate in the chronic phase. LB progress from an early (ELB) to a late (LLB) stage, defined according to their progressive capacity to generate cholesterol crystals, resembling atherosclerotic lesions. FM arise from massive accumulation of LLB. Electronic microscopy reveals intracellular lipophilic inclusions (ILIs) in those M. tuberculosis bacilli inside FM. It is our hypothesis that the accumulation of lipids in M. tuberculosis concomitant to the establishment of the non-replicating state prepares the bacilli for future reactivation and for facing future stressful environments.
- Published
- 2009
- Full Text
- View/download PDF
133. Induction of a Specific Strong Polyantigenic Cellular Immune Response after Short-Term Chemotherapy Controls Bacillary Reactivation in Murine and Guinea Pig Experimental Models of Tuberculosis
- Author
-
Cristina Vilaplana, Olga Gil, Mahavir Singh, Neus Cáceres, Evelyn Guirado, and Pere-Joan Cardona
- Subjects
Microbiology (medical) ,Cellular immunity ,Time Factors ,T-Lymphocytes ,Guinea Pigs ,Clinical Biochemistry ,Immunology ,Antitubercular Agents ,Biology ,Microbiology ,Mycobacterium tuberculosis ,Interferon-gamma ,Mice ,Immune system ,Antigen ,Isoniazid ,medicine ,Animals ,Humans ,Immunology and Allergy ,Interferon gamma ,Tuberculosis Vaccines ,Tuberculosis, Pulmonary ,Antigens, Bacterial ,Vaccine Research ,biology.organism_classification ,Acquired immune system ,Specific Pathogen-Free Organisms ,Mice, Inbred C57BL ,Treatment Outcome ,Liposomes ,BCG Vaccine ,Female ,Rifampin ,Tuberculosis vaccines ,BCG vaccine ,medicine.drug - Abstract
RUTI is a therapeutic vaccine that is generated from detoxified and liposomedMycobacterium tuberculosiscell fragments that has demonstrated its efficacy in the control of bacillus reactivation after short-term chemotherapy. The aim of this study was to characterize the cellular immune response generated after the therapeutic administration of RUTI and to corroborate the lack of toxicity of the vaccine. Mouse and guinea pig experimental models were infected with a low-doseM. tuberculosisaerosol. RUTI-treated animals showed the lowest bacillary load in both experimental models. RUTI also decreased the percentage of pulmonary granulomatous infiltration in the mouse and guinea pig models. This was not the case afterMycobacterium bovisBCG treatment. Cellular immunity was studied through the characterization of the intracellular gamma interferon (IFN-γ)-producing cells after the splenocytes' stimulation withM. tuberculosis-specific structural and growth-related antigens. Our data show that the difference between the therapeutic administration of BCG and RUTI resides mainly in the stronger activation of IFN-γ+CD4+cells and CD8+cells against tuberculin purified protein derivative, ESAT-6, and Ag85B that RUTI generates. Both vaccines also triggered a specific immune response against theM. tuberculosisstructural antigens Ag16kDa and Ag38kDa and a marked mRNA expression of IFN-γ, tumor necrosis factor, interleukin-12, inducible nitric oxide synthase, and RANTES in the lung. The results show that RUTI's therapeutic effect is linked not only to the induction of a Th1 response but also to the stimulation of a quicker and stronger specific immunity against structural and growth-related antigens that reduces both the bacillary load and the pulmonary pathology.
- Published
- 2008
- Full Text
- View/download PDF
134. The Tuberculin Skin Test Increases the Responses Measured by T Cell Interferon-Gamma Release Assays
- Author
-
J. Ruiz-Manzano, Mahavir Singh, R. Spallek, P. J. Cardona, Olga Gil, E. Montané, Vicente Ausina, F. Cuchillo, and Cristina Vilaplana
- Subjects
T-Lymphocytes ,Immunology ,Tuberculin ,Enzyme-Linked Immunosorbent Assay ,Sensitivity and Specificity ,Mycobacterium tuberculosis ,Interferon-gamma ,Bacterial Proteins ,Antigen ,medicine ,Humans ,Tuberculosis ,Interferon gamma ,Cells, Cultured ,Antigens, Bacterial ,biology ,Latent tuberculosis ,Tuberculin Test ,business.industry ,ELISPOT ,Immunogenicity ,Isoniazid ,General Medicine ,bacterial infections and mycoses ,biology.organism_classification ,medicine.disease ,Mycobacterium bovis ,Virology ,Leukocytes, Mononuclear ,business ,medicine.drug - Abstract
RUTI is a vaccine consisting of Mycobacterium tuberculosis bacilli grown in stress conditions that is fragmented, detoxified and liposomed. RUTI was designed to shorten the treatment of latent tuberculosis infection (LTBI) with isoniazid from 9 months to just 1 month, by additional treatment with two inoculations of RUTI 4 weeks apart. During the validation process for monitoring the immunogenicity of administration of RUTI in a Phase I clinical trial, the question arose whether to introduce the tuberculin skin test (TST) in the screening of non-LTBI volunteers. This study was designed to evaluate the effect of TST on subsequent different T-cell interferon-gamma release assay (TIGRA) responses, using a spectrum of M. tuberculosis-related antigens (ESAT-6, CFP-10, 16 kDa, 19 kDa, MPT64, Ag 85B, 38 kDa, hsp65, PPD and BCG). The results showed an increase in post-TST response even in non-LTBI subjects for most antigens tested, as measured both by whole blood assay (WBA) and ELISPOT. Increased ELISPOT response decreased toward pre-TST levels within 1 month whereas the WBA response did not. Taking into account that there is no definitive correlation between TST and TIGRA tests to diagnose LTBI and the feasibility that TST might alter the immune monitoring included in clinical trials, these data suggest that TST determination should be carefully planned to avoid any interference with TIGRA.
- Published
- 2008
- Full Text
- View/download PDF
135. Evaluation of a Legionella urinary antigen enzyme immunoassay for rapid detection of Legionella pneumophila in water samples
- Author
-
D. Ferrer, José Domínguez, T. Pellicer, L. Haba, Cristina Prat, Silvia Blanco, María Dolores Baucells Sánchez, Vicente Ausina, Cristina Vilaplana, and Irene Latorre
- Subjects
Detection limit ,Antigens, Bacterial ,biology ,medicine.diagnostic_test ,Serial dilution ,Legionella ,Cell Culture Techniques ,Public Health, Environmental and Occupational Health ,Enzyme-Linked Immunosorbent Assay ,bacterial infections and mycoses ,Isolation (microbiology) ,biology.organism_classification ,Sensitivity and Specificity ,Legionella pneumophila ,respiratory tract diseases ,Microbiology ,Antigen ,Immunoassay ,medicine ,Humans ,bacteria ,Serotyping ,Water Microbiology ,Bacteria - Abstract
Despite advances in medium formulations and pretreatment techniques, recovery of Legionella from water samples can still be quite low, difficult and time consuming. The aim of this study was to evaluate the utility of a Legionella urinary antigen enzyme immunoassay (Bartels ELISA, Trinity Biotech, Ireland) for the detection of Legionella in water samples. Reference ATCC Legionella strains were used to spike water samples to a final concentration of 10 4 –10 5 cfu/ml. The lower detection limit of the test for all Legionella pneumophila serogroups was assessed by serial dilutions of spiked water samples. Legionella antigen was detected in all filtered samples except for those spiked with L. bozemanii and L. longbeachae . The lower detection limit for soluble L. pneumophila serogroup 1 antigen was 780 cfu/ml. Bartels ELISA could be a useful method for antigen detection in water samples when a high recovery of L. pneumophila is suspected. The test could be used as a rapid screening method for the detection of Legionella in a large number of samples. However, the low sensitivity of the test requires to keep on performing conventional culture for isolation and for further studies on isolated bacteria.
- Published
- 2008
- Full Text
- View/download PDF
136. Interactions between Private Health and Long-term Care Insurance and the Effects of the Crisis: Evidence for Spain
- Author
-
Sergi, Jiménez-Martín, José M, Labeaga-Azcona, and Cristina, Vilaplana-Prieto
- Subjects
Male ,Retirement ,Insurance, Health ,Health Policy ,Consumer Behavior ,Middle Aged ,Health Surveys ,Long-Term Care ,Economic Recession ,Insurance, Long-Term Care ,Spain ,Income ,Humans ,Female ,Private Sector - Abstract
This paper analyzes the reasons for the scarce development of the private long-term care insurance market in Spain, and its relationship with health insurance. We are also interested in the effects the crisis has had both on the evolution of the demand for long-term care insurance and on the existence of regional disparities. We estimate bivariate probit models with endogenous variables using Spanish data from the Survey on Health and Retirement in Europe. Our results confirm that individuals wishing to purchase long-term care insurance are, in a sense, forced to subscribe a health insurance policy. In spite of this restriction in the supply of long-term care insurance contracts, we find its demand has grown in recent years, which we attribute to the budget cuts affecting the implementation of Spain's System of Autonomy and Attention to Dependent People. Regional differences in its implementation, as well as the varying effects the crisis has had across Spanish regions, lead to the existence of a crowding-in effect in the demand for long-term care insurance in those regions where co-payment is based on income and wealth, those that have a lower percentage of public long-term care beneficiaries, or those with a smaller share of cash benefits over total public benefits. Copyright © 2016 John WileySons, Ltd.
- Published
- 2015
137. How Financial Education affects Mathematics performance? Evidence from Spain in the context of the Program School 2.0
- Author
-
Cristina Vilaplana-Prieto
- Subjects
Finance ,Engineering ,business.industry ,Teaching ,Educational systems ,Context (language use) ,Subject (documents) ,Higher Education ,Learning effect ,Reform mathematics ,Mathematics education ,ComputingMilieux_COMPUTERSANDEDUCATION ,Learning ,business ,Mathematics - Abstract
In this paper we evaluate the effect of the Program School 2.0 on both Financial Education and Mathematics performance using data from PISA 2012. The Program Shool 2.0 was implemented in 2009 in some Spanish Autonomoous Communities. This program promoted the use of computers, both in school and at home, among elementary and high school students. We detect that a greater benefit is obtained when the contents of Financial Educaton are taught in conjunction with the contents of the subject of Mathematics, although the mean effect of Financial Education over Mathematics is more intense in the Communities that have not participated in the Program School 2.0. This result may be related to the fact that only a moderate use of computers for personal use increases Mathematics and Financial Education performance. Nevertheles, given the recent implementation of the Program School 2.0, we should expect some "learning effects" that should be confirmed with future data. DOI: http://dx.doi.org/10.4995/HEAd15.2015.238
- Published
- 2015
- Full Text
- View/download PDF
138. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis
- Author
-
Michael Meuli, Pål Johansen, Peter Sander, Emma Rayner, Gregory J. Bancroft, Deepa Mohanan, Ann Williams, Pere-Joan Cardona, Simon Clark, Michael Dal Molin, Cristina Vilaplana, Agnese Petrera, Andrea Zelmer, Nuria Andreu, Petra Selchow, Erik C. Böttger, University of Zurich, and Sander, Peter
- Subjects
Tuberculosis ,Deletion mutant ,Denmark ,3400 General Veterinary ,Mutant ,Guinea Pigs ,610 Medicine & health ,Vaccines, Attenuated ,complex mixtures ,Guinea pig ,Mice ,Bacterial Proteins ,2400 General Immunology and Microbiology ,medicine ,Animals ,Tuberculosis Vaccines ,Lung ,Metalloproteinase ,Mycobacterium bovis ,Granuloma ,General Veterinary ,General Immunology and Microbiology ,biology ,10179 Institute of Medical Microbiology ,Immunogenicity ,Public Health, Environmental and Occupational Health ,10177 Dermatology Clinic ,2739 Public Health, Environmental and Occupational Health ,2725 Infectious Diseases ,medicine.disease ,biology.organism_classification ,Virology ,Bacterial Load ,3. Good health ,Safety profile ,Disease Models, Animal ,Infectious Diseases ,1313 Molecular Medicine ,Mutation ,Metalloproteases ,Molecular Medicine ,570 Life sciences ,Gene Deletion ,Spleen - Abstract
Having demonstrated previously that deletion of zinc metalloprotease zmp1 in Mycobacterium bovis BCG increased immunogenicity of BCG vaccines, we here investigated the protective efficacy of BCG zmp1 deletion mutants in a guinea pig model of tuberculosis infection. zmp1 deletion mutants of BCG provided enhanced protection by reducing the bacterial load of tubercle bacilli in the lungs of infected guinea pigs. The increased efficacy of BCG due to zmp1 deletion was demonstrated in both BCG Pasteur and BCG Denmark indicating that the improved protection by zmp1 deletion is independent from the BCG sub-strain. In addition, unmarked BCG Δzmp1 mutant strains showed a better safety profile in a CB-17 SCID mouse survival model than the parental BCG strains. Together, these results support the further development of BCG Δzmp1 for use in clinical trials.
- Published
- 2015
- Full Text
- View/download PDF
139. Towards host-directed therapies for tuberculosis
- Author
-
Abraham Aseffa, Alimuddin Zumla, Leonard Maboko, Gita Ramjee, Timothy D. McHugh, Robert S. Wallis, Marco Schito, Neil A. Martinson, Stefan H. E. Kaufmann, Niaina Rakotosamimanana, Ian Sanne, Sayoki Mfinanga, Roxana Rustomjee, Francine Ntoumi, Voahangy Rasolofo, Cristina Vilaplana, Gibson S. Kibiki, Salim Abdulla, Nathan Kapata, Klaus Reither, Jeremiah Chakaya, Vanya Gant, Sebastien Gagneux, Michael Hoelscher, Bongani M. Mayosi, Mahdad Noursadeghi, Nesri Padayatchi, Giuseppe Ippolito, Tandakha Ndiaye Dieye, Sarah Edwards, Eleni Aklillu, James B.W. Russell, Elirehema Mfinanga, Christian Wejse, Pontiano Kaleebu, Martin Rao, Modest Mulenga, Martin P. Grobusch, Peter Mwaba, Maryline Bonnet, Eskild Petersen, Eusebio Macete, Matthew Bates, Robert J. Wilkinson, Alberto L. García-Basteiro, Thomas Nyirenda, Dorothy Yeboah-Manu, Nalini Singh, Almoustapha Issiaka Maiga, Rajhmun Madansein, Paula Munderi, Clara Menendez, Pere-Joan Cardona, Gavin J. Churchyard, Tumena Corrah, Paul T. Elkington, Aziz Sheikh, Martin Antonio, Andrie Steyn, Leopold D. Tientcheu, Bassirou Diarra, Matt Oliver, Markus Maeurer, Gill Craig, Shreemanta Parida, Graduate School, Other departments, AII - Amsterdam institute for Infection and Immunity, APH - Amsterdam Public Health, and Infectious diseases
- Subjects
Tuberculosis ,medicine.drug_class ,Antibiotics ,Antitubercular Agents ,Drug resistance ,Pharmacology ,Bioinformatics ,Mycobacterium tuberculosis ,Drug Discovery ,Medicine ,Humans ,Molecular Targeted Therapy ,clinical trials ,biology ,business.industry ,Treatment regimen ,General Medicine ,biology.organism_classification ,medicine.disease ,3. Good health ,Clinical trial ,tuberculosis ,Drug Design ,Drug Therapy, Combination ,business ,RC - Abstract
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.\ud \ud Despite the availability of effective antibiotics for tuberculosis (TB) for the past half century, it remains an important global health problem; there are ~9 million active TB cases and ~1.5 million TB-induced deaths per year (see the World Health Organization (WHO) Global Tuberculosis Report in Further information). Health services around the world face major barriers to achieving optimal outcomes from current TB treatment regimens. These barriers include: the spread of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB); complex and toxic treatment regimens for MDR-TB; HIV co-infection; pharmacokinetic interactions between TB drugs and antiretroviral drugs; relapse; permanent damage to lung and other tissues; long-term functional disability; immune reconstitution inflammatory syndrome (IRIS); and co-morbidity with non-communicable diseases such as diabetes and chronic obstructive airway diseases. Another fundamental problem is the long duration of TB drug treatment (6 months for drug-sensitive TB and at least 18 months for drug-resistant TB) to achieve a cure, owing to the presence of dormant Mycobacterium tuberculosis bacilli that are phenotypically resistant to current classes of anti-TB drugs, which can only target bacterial replication.\ud \ud There is therefore an urgent need for new TB treatments. However, the TB drug pipeline is thin1, 2. For the past 60 years, efforts to develop new treatments have focused on compounds and regimens that target M. tuberculosis directly. Recently, however, attention has focused on investigating a range of adjunct treatment interventions known as host-directed therapies (HDTs) that instead target the host response to infection. Here, we highlight the rationale for HDTs, the current portfolio of HDTs and their mechanisms of action, and a consortium-based approach to drive forward their evaluation in clinical trials.
- Published
- 2015
- Full Text
- View/download PDF
140. Usefulness of acr Expression for Monitoring Latent Mycobacterium tuberculosis Bacilli in 'In Vitro' and 'In Vivo' Experimental Models
- Author
-
Evelyn Guirado, Sonia Molinos, Isabel Amat, Vicente Ausina, Jorge Díaz, Cristina Vilaplana, P. J. Cardona, Sergi Gordillo, and Olga Gil
- Subjects
Genetic Markers ,Bacilli ,Tuberculosis ,medicine.drug_class ,Immunology ,Antibiotics ,Sigma Factor ,Microbiology ,Mycobacterium tuberculosis ,Mice ,Bacterial Proteins ,In vivo ,Sigma factor ,medicine ,Animals ,alpha-Crystallins ,biology ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Regulation, Bacterial ,General Medicine ,medicine.disease ,biology.organism_classification ,Isocitrate Lyase ,In vitro ,Specific Pathogen-Free Organisms ,Disease Models, Animal ,Female ,Tumor necrosis factor alpha - Abstract
Real-time RT-PCR was used to quantify the expression of genes possibly involved in Mycobacterium tuberculosis latency in in vitro and murine models. Exponential and stationary phase (EP and SP) bacilli were exposed to decreasing pH levels (from 6.5 to 4.5) in an unstirred culture, and mRNA levels for 16S rRNA, sigma factors sigA,B,E,F,G,H and M, Rv0834c, icl, nirA, narG, fpbB, acr, rpoA, recA and cysH were quantified. The expression of acr was the one that best correlated with the CFU decrease observed in SP bacilli. In the murine model, the expressions of icl, acr and sigF tended to decrease when bacillary counts increased and vice versa. Values from immunodepressed mice (e.g. alpha/beta T cells, TNF, IFN-gamma and iNOs knock out strains), with accelerated bacillary growth rate, confirmed this fact. Finally, the expression of acr was maintained in mice following long-term treatment with antibiotics. The quantification of acr expression could be useful for monitoring the presence of latent bacilli in some murine models of tuberculosis.
- Published
- 2006
- Full Text
- View/download PDF
141. Intragranulomatous necrosis in pulmonary granulomas is not related to resistance against Mycobacterium tuberculosis infection in experimental murine models induced by aerosol
- Author
-
Vicenç Ausina, Gustavo Tapia, Pere-Joan Cardona, Jorge Díaz, Evelyn Guirado, Sergi Gordillo, Olga Gil, and Cristina Vilaplana
- Subjects
Tuberculosis ,Necrosis ,Lung ,Lipopolysaccharide ,biology ,Ratón ,business.industry ,Cell Biology ,medicine.disease ,biology.organism_classification ,Pathology and Forensic Medicine ,Mycobacterium tuberculosis ,chemistry.chemical_compound ,medicine.anatomical_structure ,chemistry ,Granuloma ,Immunology ,medicine ,Pulmonary pathology ,medicine.symptom ,business ,Molecular Biology - Abstract
Intragranulomatous necrosis is a primary feature in the natural history of human tuberculosis (TB). Unfortunately, this phenomenon is not usually seen in the experimental TB murine model. Artificial induction of this necrosis in pulmonary granulomas (INPG) may be achieved through aerosol inoculation of lipopolysaccharide (LPS) 3 weeks after Mycobacterium tuberculosis infection. At week 9 post-infection, the centre of primary granulomas became larger, showing eosinophilic necrosis. Interestingly, INPG induction was related to mice strains C57BL/6 and 129/Sv, but not to BALB/c and DBA/2. Furthermore, the same pattern was obtained with the induction of infection using a clinical M. tuberculosis strain (UTE 0335R) that naturally induces INPG. In all the mice strains tested, the study of pulmonary mRNA expression revealed a tendency to increase or to maintain the expression of RANTES, interferon-gamma, tumour necrosis factor and iNOS, in both LPS- and UTE 0335R-induced INPG, thus suggesting that this response must be necessary but not sufficient for inducing INPG. Our work supports that INPG induction is a local phenomenon unrelated to the resistant (C57BL/6 and BALB/c) or susceptible (129/Sv and DBA/2) background of mice strains against M. tuberculosis infection.
- Published
- 2006
- Full Text
- View/download PDF
142. Intragranulomatous necrosis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type
- Author
-
Olga Gil, Gustavo Tapia, Evelyn Guirado, Pere-Joan Cardona, Sergi Gordillo, Vicenç Ausina, Jorge Díaz, Aurelio Ariza, and Cristina Vilaplana
- Subjects
Necrosis ,medicine.medical_treatment ,T cell ,Immunology ,Biology ,Microbiology ,Mice ,T-Lymphocyte Subsets ,medicine ,Animals ,RNA, Messenger ,Lung ,Tuberculosis, Pulmonary ,Mice, Knockout ,Cord factor ,Karyorrhexis ,Alveolar septum ,Mice, Inbred C57BL ,Infectious Diseases ,Cytokine ,medicine.anatomical_structure ,Gene Expression Regulation ,Cytokines ,Female ,Tumor necrosis factor alpha ,medicine.symptom ,CD8 - Abstract
Low dose aerosol infection of C57BL/6 mice with a clinical strain of Mycobacterium tuberculosis (UTE 0335 R) induced intragranulomatous necrosis in pulmonary granulomas (INPG) at week 9 postinfection. Infection of different knockout (KO) mouse strains with UTE 0335 R induced INPG in all strains and established two histopathological patterns. The first pattern was seen in SCID mice and in mice with deleted alpha/beta T receptor, TNF R1, IL-12, IFN-gamma, or iNOS genes, and showed a massive INPG with a high granulomatous infiltration of the lung, a large and homogeneous eosinophilic necrosis full of acid-fast bacilli, with marked karyorrhexis, coarse basophilic necrosis, and surrounded by patches delimited by partially conserved alveolar septum full of PMNs. The second pattern was seen in mice with deleted IL-1 R1, IL-6, IL-10, CD4, CD8 or gamma/delta T cell receptor genes, and showed more discrete lesions with predominant homogeneous eosinophilic necrosis with few bacilli and surrounded by a well-defined lymphocyte-based ring. Local expression of IFN-gamma, iNOS, TNF and RANTES showed no significant differences between these mouse strains generating a discrete INPG. Mouse strains showing a massive INPG showed higher, lower or equal expression values compared to the control strain. In conclusion, the severity of the INPG pattern correlated with pulmonary CFU counts, irrespective of the genetic absence or the infection-induced levels of cytokine mediators.
- Published
- 2006
- Full Text
- View/download PDF
143. A sequential model of older workers' labor force transitions after a health shock
- Author
-
Cristina Vilaplana Prieto, Sergi Jimenez-Martin, and José M. Labeaga
- Subjects
Employment ,Male ,Labour economics ,Demographics ,Health Status ,Health Policy ,Work (physics) ,Middle Aged ,Disability Evaluation ,Shock (economics) ,Cross-Sectional Studies ,Spain ,Spouse ,Surveys and Questionnaires ,Economics ,Humans ,Female ,Demographic economics ,Sequential model ,Models, Econometric ,Retrospective Studies - Abstract
In this work we study older workers’ (50—64) labor force transitions after a health/disability shock. We find that the probability of keeping working decreases with both age and severity of the shock. Moreover, we find strong interactions between age and severity in the 50—64 age range and none in the 30–49 age range. Regarding demographics we find that being female and married reduce the probability of keeping work. On the contrary, being main breadwinner, education and skill levels increase it. Interestingly, the effect of some demographics changes its sign when we look at transitions from inactivity to work. This is the case of being married or having a working spouse. Undoubtedly, leisure complementarities should play a role in the latter case. Since the data we use contains a very detailed information on disabilities, we are able to evaluate the marginal effect of each type of disability either in the probability of keeping working or in returning back to work. Some of these results may have strong policy implications.
- Published
- 2006
- Full Text
- View/download PDF
144. Selected culture and drug-susceptibility testing methods for drug-resistantMycobacterium tuberculosisscreening in resource-constrained settings
- Author
-
Gema Fernández-Rivas, Cristina Vilaplana Messeguer, and Vicente Ausina Ruiz
- Subjects
Tuberculosis ,Manual MGIT ,Resource constrained ,NRA in liquid medium ,Drug resistant tuberculosis ,Drug susceptibility ,Rifampicin resistance ,Drug resistance ,Biology ,medicine.disease ,biology.organism_classification ,Pathology and Forensic Medicine ,Microbiology ,Mycobacterium tuberculosis ,Determination of drug sensitivity ,Genetics ,medicine ,Molecular Medicine ,Mycobacteria growth indicator tube ,Agar proportion method ,Molecular Biology ,Rifampicin ,Research Article ,medicine.drug - Abstract
Background Tuberculosis (TB) is a disease of poverty that contributes significantly to ill-health in developing countries. Drug resistant TB is a major challenge to disease control. Early diagnosis and rapid determination of drug sensitivity is of paramount importance in eradication of TB. Although automated liquid culture based methods are available for rapid detection of drug resistance, the high cost of these tests prevent them from being used routinely in low resource settings. This study compares two phenotypic methods, the manual Mycobacteria Growth Indicator Tube (MGIT) and the Nitrate Reductase Assay (NRA) in liquid medium, with the agar proportion method (APM), the gold standard for susceptibility testing of Mycobacterium tuberculosis. Methodology Fourteen day old M. tuberculosis strains (n=373) grown on solid media were used for drug susceptibility testing by APM, NRA and the manual MGIT method. Rifampicin free and rifampicin incorporated (final concentration, 1 μg/ml) media were inoculated with the recommended concentrations of mycobacterial suspensions and incubated at 37°C in 5% CO2. In the APM, the proportion of colonies in the drug containing medium was determined. In the NRA, the colour change in the medium was compared with a standard colour series after day 6 and day 12 of incubation. Growth in the MGIT was detected using the manual MGIT reader from day 2 onwards. The 2 methods were compared with the gold standard, APM to determine sensitivity and specificity and agreement between the methods was calculated using kappa statistics. Results Thirty one (31) rifampicin resistant isolates were identified. When compared with the APM, the sensitivity of detection of rifampicin resistance was 85% for the NRA and 93% for the manual MGIT and the specificity was 99% and 100% respectively. Both assays, NRA (κ=0.86) and manual MGIT method (κ= 0.94) were in excellent agreement with the APM. The mean turnaround time for manual MGIT method and NRA were 08 days and 10 days respectively. Conclusion The NRA in liquid medium and manual MGIT are useful alternatives to APM for drug susceptibility testing of M. tuberculosis in low resource settings.
- Published
- 2013
- Full Text
- View/download PDF
145. Hydroxytyrosol and Potential Uses in Cardiovascular Diseases, Cancer, and AIDS
- Author
-
David Auñón, Angel Gil-Izquierdo, Libia Alejandra García-Flores, Cristina Vilaplana-Pérez, Comisión Interministerial de Ciencia y Tecnología, CICYT (España), and Consejo Superior de Investigaciones Científicas (España)
- Subjects
Antioxidant ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,lcsh:TX341-641 ,Disease ,Review Article ,phenolic compounds ,Antioxidants ,chemistry.chemical_compound ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Nutrition ,disease ,Nutrition and Dietetics ,Traditional medicine ,business.industry ,Cancer ,medicine.disease ,Food safety ,olive oil ,Bioavailability ,chemistry ,Hydroxytyrosol ,anti-oxidants ,business ,lcsh:Nutrition. Foods and food supply ,hydroxytyrosol ,Food Science ,Olive oil - Abstract
Hydroxytyrosol is one of the main phenolic components of olive oil. It is present in the fruit and leaf of the olive (Olea europaea L.). During the past decades, it has been well documented that this phenolic compound has health benefits and a protective action has been found in preclinical studies against several diseases. Here, we review its bioavailability in human beings and several assays showing significant results related with cardiovascular diseases, cancer, and acquired immunodeficiency syndrome (AIDS). Mechanisms of action include potent anti-oxidant and anti-inflammatory effects, among others. The importance of hydroxytyrosol in protection of low-density lipoproteins and consequently its implication in the reduction of cardiovascular disease risk has been highlighted by the European Food Safety Authority, concluding that 5 mg of hydroxytyrosol and its derivatives should be consumed daily to reach this effect at physiological level. We discuss the potential uses of this compound in supplements, nutraceutic foods, or topical formulations in the disease risk reduction. Finally, we conclude that more studies are needed to sustain or reject many other health claims not yet fully documented and to validate these newly available hydroxytyrosol-based products, because it seems to be a good candidate to reduce the risk of diseases mentioned., This study was supported by the projects AGL2011-23690 (CICYT), and CSIC 201170E041 (Spanish Ministry of Economy and Competitiveness). Libia A. García-Flores was granted a pre-doctoral FPI, fellowship program from the Spanish government.
- Published
- 2014
146. Informal care motivations and intergenerational transfers in European countries
- Author
-
Sergi, Jiménez-Martín and Cristina, Vilaplana Prieto
- Subjects
Adult ,Male ,Motivation ,Age Factors ,Middle Aged ,Models, Theoretical ,Nurses, Community Health ,Long-Term Care ,Europe ,Sex Factors ,Caregivers ,Intergenerational Relations ,Income ,Adult Children ,Humans ,Female ,Aged - Abstract
This work sets out to analyze the motivations adult children may have to provide informal care, considering the monetary transfers they receive from their parents. Traditional motivations, such as altruism and exchange, are matched against more recent social bond theories. Our findings indicate that informal caregivers receive less frequent and less generous transfers than non-caregivers; that is, caregivers are more prone to suppress their self-interested motivations in order to prioritize the well being of another person. Additionally, long-term public care benefits increase both the probability of receiving a transfer and its amount, with this effect being more intense for both the poorest and richest households. Our findings suggest that if long-term care benefits are intended to increase the recipients' welfare and represent a higher fraction of total income for the poorest households, the effectiveness of these long-term care policies may be diluted.
- Published
- 2014
147. Will we be treating tuberculosis with vaccines in the XXI century?
- Author
-
Juan, Ruiz Manzano and Cristina, Vilaplana
- Subjects
Humans ,Tuberculosis ,Tuberculosis Vaccines ,Forecasting - Published
- 2014
148. Informal Care and intergenerational transfers in European Countries
- Author
-
Sergi Jiménez-Martín and Cristina Vilaplana Prieto
- Abstract
In a world in which the welfare state is under pressure, understanding the dynamic effects of money transfers from parents to adult children and their relationship with informal care can be relevant for policy purposes. We use the first two waves of the Survey of Health and Retirement in Europe (SHARE) to estimate a double-hurdle model for a parental decision to provide financial support for adult children and the amount involved, taking into account the potential endogeneity of informal caregiving. We find that informal caregivers receive less frequent transfers and less generous amounts than non-caregivers. This offers support for the idea of a form of sophisticated altruistic behavior, according to which caregiving costs are outweighed by the parent’s benefits. Regarding public policies, we find that while increased unemployment benefits would not generate any crowding-out effect in parental transfers, a reduction in long-term public care benefits has a negative multiplier effect on parental transfers.
- Published
- 2013
149. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis
- Author
-
Gustavo Tapia, Elena Marzo, Pere-Joan Cardona, Vanessa Rubio García, Cristina Vilaplana, and Jorge Díaz
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Pathology ,Chemokine CXCL5 ,Tuberculosis ,Neutrophils ,Immunology ,Anti-Inflammatory Agents ,Inflammation ,Caseous necrosis ,Microbiology ,Mycobacterium tuberculosis ,Mice ,Immune system ,Liquefactive necrosis ,medicine ,Animals ,Immunity, Cellular ,Mice, Inbred C3H ,Granuloma ,biology ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Interleukin-17 ,medicine.disease ,biology.organism_classification ,Immunohistochemistry ,Disease Models, Animal ,Infectious Diseases ,Neutrophil Infiltration ,Disease Progression ,Histopathology ,Female ,medicine.symptom ,Biomarkers - Abstract
Summary Tuberculosis was studied using an experimental model based on the C3HeB/FeJ mouse strain, which mimics the liquefaction of caseous necrosis occurring during active disease in immunocompetent adults. Mice were intravenously infected with 2 × 10 4 Colony Forming Units of Mycobacterium tuberculosis and their histopathology, immune response, bacillary load, and survival were evaluated. The effects of the administration of drugs with anti-inflammatory activity were examined, and the C3H/HeN mouse strain was also included for comparative purposes. Massive intra-alveolar neutrophilic infiltration led to rapid granuloma growth and coalescence of lesions into superlesions. A central necrotic area appeared showing progressive cellular destruction, the alveoli cell walls being initially conserved (caseous necrosis) but finally destroyed (liquefactive necrosis). Increasing levels of pro-inflammatory mediators were detected in lungs. C3HeB/FeJ treated with anti-inflammatory drugs and C3H/HeN animals presented lower levels of pro-inflammatory mediators such as TNF-α, IL-17, IL-6 and CXCL5, a lower bacillary load, better histopathology, and increased survival compared with untreated C3HeB/FeJ. The observation of massive neutrophilic infiltration suggests that inflammation may be a key factor in progression towards active tuberculosis. On the basis of our findings, we consider that the C3HeB/FeJ mouse model would be useful for evaluating new therapeutic strategies against human tuberculosis.
- Published
- 2013
150. Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis
- Author
-
Vanesa Garcia, Gustavo Tapia, Pere-Joan Cardona, Jorge Díaz, Elena Marzo, and Cristina Vilaplana
- Subjects
Tuberculosis ,Anti-Inflammatory Agents ,Ibuprofen ,Mycobacterium tuberculosis ,Mice ,medicine ,Immunology and Allergy ,Animals ,Mice, Inbred C3H ,Lung ,biology ,Experimental model ,business.industry ,medicine.disease ,Active tuberculosis ,biology.organism_classification ,Clinical trial ,Experimental animal ,Disease Models, Animal ,Infectious Diseases ,medicine.anatomical_structure ,Immunology ,Female ,business ,medicine.drug - Abstract
C3HeB/FeJ mice infected with Mycobacterium tuberculosis were used in an experimental animal model mimicking active tuberculosis in humans to evaluate the effect of antiinflammatory agents. No other treatment but ibuprofen was given, and it was administered when the animals' health started to deteriorate. Animals treated with ibuprofen had statistically significant decreases in the size and number of lung lesions, decreases in the bacillary load, and improvements in survival, compared with findings for untreated animals. Because antiinflammatory agents are already on the market, further clinical trials should be done to evaluate this effect in humans as soon as possible, to determine their suitability as coadjuvant tuberculosis treatment.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.